-
Walgreens Boots Alliance secures 10-year own brand manufacturing agreement
DEERFIELD, Ill. — Walgreens Boots Alliance on Wednesday announces a binding offer from Fareva for a 10-year global agreement for the manufacture and supply of own beauty brands and private label products, including products for sale in the U.S.
"The proposed agreement will create a partnership to provide Walgreens Boots Alliance with a core multinational manufacturing and development resource, enabling the company to accelerate its global product strategy," Walgreens Boots Alliance stated.
-
Proposed CMS cuts to 340B will have negligible impact, Walgreens says
DEERFIELD, Ill. — Walgreens Boots Alliance met with various investors to clarify its participation in the U.S. Health Resources and Services Administration 340B drug pricing program.
For the first nine months of fiscal 2017, prescriptions related to the 340B program represented less than 1% of the Retail Pharmacy USA division’s prescription volume, Walgreens noted. The division has around 1,200 340B contracts. During the first nine months of fiscal 2017, 340B prescriptions were filled at approximately 6,100 of the division’s pharmacies.